[Estimation of economic burden of bacillus Calmette-Guérin lymphadenitis in Shandong Province based on compensation for abnormal reaction to vaccination]
- PMID: 35092989
- DOI: 10.3760/cma.j.cn112150-20210226-00193
[Estimation of economic burden of bacillus Calmette-Guérin lymphadenitis in Shandong Province based on compensation for abnormal reaction to vaccination]
Abstract
Objective: To investigate the economic burden of bacillus Calmette-Guérin (BCG) lymphadenitis in Shandong Province. Methods: From May 2011 to December 2019, 304 patients applying for the province-level compensation of BCG lymphadenitis was selected from Shandong Province in this study. The basic situation, vaccination, outpatient (inpatient) records, cost and relevant information of those patients were collected to calculate the direct economic burden (including direct medical costs and direct non-medical costs), indirect economic burden and total economic burden. Comparison of the difference of economic burden of cases with different characteristics was taken. Results: The M(Q1,Q3) of age of BCG lymphadenitis patients was 3 (2, 4) months, among which 239 cases (78.6%) were male, 71 cases (23.4%) had lymphadenopathy, and 227 cases (74.7%) underwent surgery.The number of outpatient only, inpatient only and outpatient then inpatient was 25.7% (78 cases), 7.2% (22 cases) and 67.1% (204 cases), respectively. The M(Q1,Q3) of direct, indirect and total economic burden of single case after discount was 9 910 (5 713, 16 074), 2 081 (1 547, 3 122) and 12 262 (7 694, 18 571) yuan, respectively.The direct medical expenses accounted for 89.4% of the direct economic burden, the direct economic burden accounted for 84.9% of the total economic burden, the total economic burden of 80.0% cases accounted for only about 20.0% of the compensation amount, and the total economic burden of only 2.3% cases accounted for more than 60.0% of the compensation amount.The direct, indirect and total economic burden of patients with inpatient only and outpatient then inpatient was higher than that of patients with outpatient only; the direct, indirect and total economic burden of patients with operation was higher than that of patients with non-operation; the direct and total economic burden of patients with unulcerated lymph node was higher than that of patients with ulcerated lymph node(all P values<0.05). Conclusion: The economic burden of BCG lymphadenitis cases in Shandong Province is influenced by the mode of diagnosis and treatment, with direct medical expenses as the predominant component.
目的： 了解山东省卡介苗（BCG）淋巴结炎经济负担情况。 方法： 以2011年5月至2019年12月山东省304例申请省级补偿的BCG淋巴结炎病例为对象，收集患者基本情况、预防接种相关情况、门诊（住院）病历和收费票据等相关资料，对其直接经济负担（包括直接医疗费用和直接非医疗费用）、间接经济负担和总经济负担进行测算，比较不同特征病例经济负担的差异。 结果： 304例BCG淋巴结炎患者月龄的M（Q1，Q3）为3（2，4）月，其中男性239例（78.6%），淋巴结破溃71例（23.4%），手术227例（74.7%）。单纯门诊、单纯住院和门诊后住院病例分别占25.7%（78例）、7.2%（22例）和67.1%（204例）。贴现后单例直接、间接和总经济负担的M（Q1，Q3）分别为9 910（5 713，16 074）、2 081（1 547，3 122）和12 262（7 694，18 571）元。直接医疗费用占直接经济负担的89.4%，直接经济负担占总经济负担的84.9%，80.0%病例的总经济负担仅占其补偿金额的20.0%左右，只有2.3%的病例总经济负担占补偿金额的60.0%以上。单纯住院和门诊后住院病例的直接、间接和总经济负担高于单纯门诊病例，手术病例的直接、间接和总经济负担高于非手术病例，淋巴结未破溃病例的直接和总经济负担高于破溃病例（均P<0.05）。 结论： 山东省BCG淋巴结炎病例经济负担受诊疗方式的影响，且以直接医疗费用为主。.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
